52 results
8-K
EX-99.1
STTK
Shattuck Labs Inc
2 May 24
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights
7:00am
, 2024, cash and cash equivalents and investments were $114.6 million, as compared to $135.5 million as of March 31, 2023.
Research and Development (R&D … : plans for our preclinical studies, clinical trials and research and development programs; plans for expansion of clinical trials; the anticipated timing
8-K
EX-99.1
STTK
Shattuck Labs Inc
4 Mar 24
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
7:14am
, progress, and expected results of Shattuck’s preclinical studies, clinical trials and research and development programs; expectations regarding
8-K
EX-99.1
4s90x
29 Feb 24
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
4:07pm
424B3
whkh5lz8yfxn7117f63q
2 Feb 24
Prospectus supplement
4:32pm
424B5
k2w05
22 Dec 23
Prospectus supplement for primary offering
4:00pm
8-K
btos 8v3u9
21 Dec 23
Other Events
7:31am
8-K
EX-99.1
d1zlu
13 Dec 23
Regulation FD Disclosure
6:10am
8-K
EX-99.1
70408t
9 Nov 23
Shattuck Labs Reports Third Quarter 2023 Financial Results and Recent Business Highlights
7:01am
8-K
EX-99.1
tcjyewf
10 Aug 23
Shattuck Labs Reports Second Quarter 2023 Financial Results and Recent Business Highlights
4:03pm
8-K
EX-99.1
ezcjlfq wr6nl24wjrh
9 May 23
Shattuck Labs Reports First Quarter 2023 Financial Results and Recent Business Highlights
4:05pm